Zosano Pharma Corporation Banner Image

Zosano Pharma Corporation

  • Ticker ZSAN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Zosano Pharma Corporation Logo Image
  • 51-200 Employees
  • Based in Fremont, California
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company’s transdermal microneedle system technology consists of titanium microneedlesMore coated with drug that are designed to enable rapid systemic administration of therapeutics to patients. Zosano’s lead product candidate is Qtrypta™ (M207), which is a proprietary formulation of zolmitriptan designed to be delivered via its transdermal microneedle system technology, as an acute treatment for migraine.
4.8 / 5.0 (154)

Zosano Pharma Corporation reports have an aggregate usefulness score of 4.8 based on 154 reviews.

Zosano Pharma Corporation

Most Recent Annual Report

Zosano Pharma Corporation
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports

Zosano Pharma Corporation Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!